Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (512)	10/19/1999 9:08:00 AM
From: Arthur Radley	Respond to of 626

Glad this issue is finally being resolved....even though I thought they wouldn't call them at this time. Maybe the cause for the recent down turn in the common share prices and now with the extra cash in the bank, they can move forward with the cancer and Parkinson's trials. The WSJ does have an interesting article today about the work Glaxo is doing in the area of schizophrenia gene identification...but if anything, will be years before a drug can be developed.